Open Access Review Article Article ID: AHR-3-117

    Vitamin K: A potential Liver Cancer treatment way

    Sofi a Dahlberg and Ulf Schött*

    A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago.

    Keywords: Vitamin K; Menaquinone; Hepatocellular cancer; Hepatitis; Cirrhosis; PIVKA-II

    Published on: Sep 26, 2017 Pages: 49-52

    Full Text PDF Full Text HTML DOI: 10.17352/ahr.000017
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AHR